Former Puma Biotech executive gets U.S. prison term for insider trading
June 20, 2018 at 16:28 PM EDT
BOSTON (Reuters) - A former Puma Biotechnology Inc executive was sentenced on Wednesday to 2-1/4 years in prison for trading on inside information ahead of announcements by the biopharmaceutical company about a breast cancer drug it was developing.
